DAIHAN Scientific Balance Sheet Health
Financial Health criteria checks 5/6
DAIHAN Scientific has a total shareholder equity of ₩48.7B and total debt of ₩2.5B, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are ₩64.0B and ₩15.3B respectively. DAIHAN Scientific's EBIT is ₩6.2B making its interest coverage ratio -46.9. It has cash and short-term investments of ₩12.8B.
Key information
5.1%
Debt to equity ratio
₩2.50b
Debt
| Interest coverage ratio | -46.9x |
| Cash | ₩12.81b |
| Equity | ₩48.70b |
| Total liabilities | ₩15.30b |
| Total assets | ₩64.00b |
Recent financial health updates
No updates
Recent updates
Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?
Apr 12
A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
Mar 29The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?
Mar 11Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% Yield
Feb 18We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)
Jan 24
What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?
Dec 27DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?
Nov 30Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?
Jul 14Financial Position Analysis
Short Term Liabilities: A131220's short term assets (₩44.4B) exceed its short term liabilities (₩14.7B).
Long Term Liabilities: A131220's short term assets (₩44.4B) exceed its long term liabilities (₩592.6M).
Debt to Equity History and Analysis
Debt Level: A131220 has more cash than its total debt.
Reducing Debt: A131220's debt to equity ratio has increased from 0.8% to 5.1% over the past 5 years.
Debt Coverage: A131220's debt is well covered by operating cash flow (191.7%).
Interest Coverage: A131220 earns more interest than it pays, so coverage of interest payments is not a concern.